Dr Reddys Laboratories

Market Cap (₹ Cr.)

₹1,10,649

52 Week High

7,107.45

Book Value

₹1,700

52 Week Low

5,205.55

PE Ratio

19.88

PB Ratio

3.90

PE for Sector

39.11

PB for Sector

4.60

ROE

19.74 %

ROCE

52.44 %

Dividend Yield

0.60 %

EPS

₹333.59

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

12.36 %

Net Income Growth

23.75 %

Cash Flow Change

-22.83 %

ROE

1.99 %

ROCE

0.45 %

EBITDA Margin (Avg.)

6.10 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Revenue	2,776	2,636	2,980	2,450	2,506	2,556	2,691	2,658	2,420	2,139	2,295	2,571	2,565	2,653	2,706	2,825	2,718	2,980	3,523	3,113	2,979	3,889	3,372	3,471	3,432	3,620	3,942	3,543	3,783	4,034	4,998	3,949	4,669	5,671	5,062	4,331	5,318	6,059
Expenses	1,933	1,862	1,977	2,025	2,375	1,928	2,081	1,928	2,051	1,941	1,941	1,988	2,166	2,043	2,066	2,045	2,209	2,078	2,285	2,288	2,331	2,316	2,529	2,634	2,748	2,872	3,075	2,866	2,999	3,051	3,078	3,223	3,493	3,210	3,210	3,447	3,726	3,888
EBITDA	843	775	1,003	425	131	628	611	730	369	197	354	583	400	610	639	780	509	902	1,238	825	648	1,573	843	837	685	748	866	677	785	983	1,921	727	1,176	2,461	1,852	884	1,591	2,171
Operating Profit %	28 %	26 %	32 %	17 %	-0 %	11 %	20 %	25 %	11 %	7 %	14 %	21 %	13 %	22 %	21 %	25 %	16 %	17 %	33 %	25 %	18 %	28 %	24 %	22 %	17 %	16 %	19 %	17 %	17 %	16 %	37 %	17 %	23 %	41 %	33 %	16 %	27 %	33 %
Depreciation	137	142	159	167	181	173	189	184	190	191	195	198	190	192	191	194	204	197	204	196	192	198	214	212	211	197	207	205	205	222	226	239	237	237	246	246	246	250
Interest	19	21	15	14	15	13	12	17	16	16	19	13	14	17	16	16	9	12	12	12	12	14	9	7	17	7	11	8	13	10	2	3	3	5	6	6	6	7
Profit Before Tax	688	611	829	244	-65	443	409	529	163	-10	140	372	196	401	433	570	296	693	1,021	618	444	1,362	620	618	457	545	649	464	567	752	1,693	485	937	2,220	1,601	632	1,339	1,914
Tax	116	118	147	64	62	89	67	103	-77	0	33	60	46	79	94	43	66	153	153	109	69	239	111	111	79	98	116	81	97	136	298	199	232	539	396	157	270	467
Net Profit	571	493	683	237	-39	409	313	439	223	-7	101	297	177	329	346	399	203	548	1,365	522	503	950	481	444	312	413	449	341	420	500	1,116	325	672	1,639	1,193	475	1,035	1,417
EPS in ₹	33.54	28.95	40.02	13.89	-2.26	24.13	18.91	26.49	13.46	-0.44	6.07	17.90	10.65	19.82	20.86	24.08	12.22	33.06	82.36	31.47	30.34	57.31	29.00	26.74	18.78	24.94	27.07	20.55	25.29	30.10	67.25	19.54	40.49	98.66	71.68	28.55	62.14	85.10

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	16,456	17,585	16,447	17,100	16,248	19,476	21,630	24,496	25,375	30,359
Fixed Assets	3,249	4,438	4,842	4,717	4,683	4,434	5,844	6,151	7,195	7,589
Current Assets	10,403	10,211	8,594	9,039	8,933	10,107	10,944	13,491	13,788	17,816
Capital Work in Progress	488	616	540	675	400	412	901	1,200	924	1,211
Investments	2,102	5,076	3,102	3,637	3,934	5,486	4,649	4,937	7,440	7,321
Other Assets	10,616	7,455	7,963	8,072	7,231	9,145	10,235	12,208	9,815	14,239
Total Liabilities	5,822	5,507	4,847	5,293	3,563	4,284	4,646	6,159	4,901	6,119
Current Liabilities	4,679	4,389	4,258	4,720	3,079	4,181	4,560	6,045	4,440	5,538
Non Current Liabilities	1,143	1,118	589	573	484	103	86	114	461	580
Total Equity	10,634	12,078	11,601	11,808	12,684	15,192	16,984	18,336	20,474	24,241
Reserve & Surplus	10,549	11,993	11,518	11,725	12,601	15,109	16,901	18,253	20,391	24,157
Share Capital	85	85	83	83	83	83	83	83	83	83

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-56	135	-135	54	-8	-74	1,266	-146	-1,047	89
Investing Activities	-2,031	-1,919	1,430	-1,180	-546	-1,689	-1,454	-1,990	-3,403	-3,429
Operating Activities	1,786	2,747	1,016	1,539	2,762	1,839	3,514	1,339	5,053	3,450
Financing Activities	189	-693	-2,582	-304	-2,223	-224	-794	506	-2,697	68

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Promoter	26.74 %	26.73 %	26.72 %	26.72 %	26.72 %	26.71 %	26.71 %	26.70 %	26.70 %	26.69 %	26.66 %	26.65 %	26.65 %	26.65 %
FIIs	29.03 %	29.04 %	27.76 %	27.42 %	25.16 %	25.87 %	26.26 %	27.29 %	27.25 %	27.00 %	28.20 %	28.62 %	29.14 %	27.68 %
DIIs	14.90 %	15.74 %	21.40 %	22.29 %	24.78 %	25.19 %	34.78 %	33.91 %	34.35 %	34.53 %	35.05 %	33.98 %	33.66 %	35.32 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	28.99 %	28.17 %	23.83 %	23.29 %	23.07 %	21.96 %	11.99 %	11.84 %	11.48 %	11.57 %	9.91 %	10.57 %	10.38 %	10.19 %

Show % Change

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,836.00	4,47,691.91	42.46	49,887.17	12.06	9,648	42.62	61.03
Cipla	1,651.60	1,34,956.56	30.36	26,520.66	14.17	4,155	17.77	60.15
Zydus Life Science	1,079.95	1,11,727.19	26.80	19,831.50	13.82	3,831	30.78	34.07
Dr Reddys Laboratories	6,567.80	1,10,648.92	19.88	28,905.40	12.36	5,578	-0.90	36.38
Lupin	2,224.95	1,03,570.56	45.76	20,141.50	19.94	1,936	77.69	59.35
Mankind Pharma	2,395.60	98,296.04	50.09	10,615.63	19.57	1,942	9.89	53.00
Aurobindo Pharma	1,539.15	90,940.60	25.35	29,559.25	17.55	3,169	61.17	55.58
Alkem Laboratories	6,090.30	74,370.03	34.59	12,978.42	9.84	1,811	91.18	53.74
Glenmark Pharmaceuticals	1,646.05	48,348.71	-	12,653.09	6.58	-1,831	96.52	48.26
Biocon	363.65	45,082.53	28.88	15,621.20	35.25	1,298	478.78	48.38